CellBion Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Holding
- Established
- 2010-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.cellbion.co.kr
Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard Therapy
Phase 1
Active, not recruiting
- Conditions
- mCRPCProstate Cancer
- Interventions
- First Posted Date
- 2022-09-21
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Cellbion Co., Ltd.
- Target Recruit Count
- 91
- Registration Number
- NCT05547061
- Locations
- 🇰🇷
Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of
🇰🇷Seoul National University Hospital, Seoul, Korea, Republic of
🇰🇷Asan Medical Center, Seoul, Korea, Republic of
News
No news found